| Bioactivity | Cenupatide (UPARANT) is a Urokinase-type plasminogen activator receptor (uPAR) inhibitor. Cenupatide has anti-angiogenic and anti-inflammatory efficacy[1]. |
| Name | Cenupatide |
| CAS | 1006388-38-0 |
| Sequence | Ac-Arg-{Aib}-Arg-{aMePhe}-NH2 |
| Shortening | Ac-R-{Aib}-R-{aMePhe}-NH2 |
| Formula | C28H47N11O5 |
| Molar Mass | 617.74 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. Filippo Locri, et al. UPARANT is an effective antiangiogenic agent in a mouse model of rubeosis iridis. J Mol Med (Berl). 2019, 97, 9. [2]. Cai Yuan, et al. Development of inhibitors for uPAR: blocking the interaction of uPAR with its partners. Drug Discov Today. 2021, 26, 4. |
Cenupatide
CAS: 1006388-38-0 F: C28H47N11O5 W: 617.74
Cenupatide (UPARANT) is a Urokinase-type plasminogen activator receptor (uPAR) inhibitor. Cenupatide has anti-angiogenic
Sales Email：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.